Plus   Neg

PerkinElmer To Acquire Horizon Discovery Group - Quick Facts

PerkinElmer, Inc. (PKI) and Horizon Discovery Group plc (HZD.L) have reached an agreement on the terms of a recommended all cash offer, under which PerkinElmer will acquire Horizon for approximately $383 million. The deal has a total enterprise value of approximately $368 million. Headquartered in Cambridge, UK, Horizon Discovery Group is a provider of CRISPR and RNAi reagents, cell models, cell engineering and base editing offerings.

PerkinElmer expects the acquisition to be modestly accretive to non-GAAP earnings in year-one following the close.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT